Literature DB >> 8549092

The clinical and immunological effects of cyclosporin A on patients with rheumatoid arthritis.

D M Chang1, S F Chiao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549092     DOI： 10.1007/bf02208151

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  37 in total

1.  Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

Authors:  P Tugwell; C Bombardier; M Gent; K J Bennett; W G Bensen; S Carette; A Chalmers; J M Esdaile; A V Klinkhoff; G R Kraag
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

2.  Immunologic parameters of response in patients with rheumatoid arthritis treated with cyclosporin A.

Authors:  D E Yocum; R L Wilder; S Dougherty; J H Klippel; S Pillemer; S Wahl
Journal:  Arthritis Rheum       Date:  1990-09

3.  Biotransformation and distribution in blood of cyclosporine and its metabolites.

Authors:  G Maurer; M Lemaire
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

4.  Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.

Authors:  J A Symons; N C Wood; F S Di Giovine; G W Duff
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

5.  Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis.

Authors:  B A Dijkmans; A W van Rijthoven; H S Goei The; Z L Montnor-Beckers; P C Jacobs; A Cats
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Low-dose cyclosporin A in severe psoriasis. A double-blind study.

Authors:  T Van Joost; J D Bos; F Heule; M M Meinardi
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

7.  Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients.

Authors:  M Dougados; H Awada; B Amor
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

8.  Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.

Authors:  M Krönke; W J Leonard; J M Depper; S K Arya; F Wong-Staal; R C Gallo; T A Waldmann; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.

Authors:  T J Schroeder; M E Brunson; A J Pesce; L L Hindenlang; P A Mauser; D I Ruckrigl; M L Weibel; G Wadih; M R First
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

10.  In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.

Authors:  A Granelli-Piperno
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.